P-1216. Pharmacokinetics of EL219 (SF001), a Novel, Next-Generation Polyene Antifungal: Results from the Phase 1 Dose-Escalation Trials in Healthy Adults and Phase 1 Open-Label Study in Adults with Moderate Renal Impairment

Open Forum Infect Dis · 2026 · PMC12792551

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

EL219 PK in adults with moderate RI showed a trend toward slower elimination but no significant changes compared with matched controls.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.